Cargando…

Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines

Live attenuated SIV vaccines (LAVs) remain the most efficacious of all vaccines in nonhuman primate (NHP) models of HIV/AIDS, yet the basis of their robust protection remains poorly understood. Here, we demonstrate that the degree of LAV-mediated protection against intravenous wildtype SIVmac239 cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukazawa, Yoshinori, Park, Haesun, Cameron, Mark J., Lefebvre, Francois, Lum, Richard, Coombes, Noel, Mahyari, Eisa, Hagen, Shoko, Bae, Jin Young, Reyes, Marcelo Delos, Swanson, Tonya, Legasse, Alfred W., Sylwester, Andrew, Hansen, Scott G., Smith, Andrew T., Stafova, Petra, Shoemaker, Rebecca, Li, Yuan, Oswald, Kelli, Axthelm, Michael K., McDermott, Adrian, Ferrari, Guido, Montefiori, David C., Edlefsen, Paul T., Piatak, Michael, Lifson, Jeffrey D., Sékaly, Rafick P., Picker, Louis J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493820/ https://www.ncbi.nlm.nih.gov/pubmed/22961108 http://dx.doi.org/10.1038/nm.2934

Ejemplares similares

A B cell follicle sanctuary permits persistent productive SIV infection in elite controllers
por: Fukazawa, Yoshinori, et al.
Publicado: (2015)

Profound CD4(+)/CCR5(+) T cell expansion is induced by CD8(+) lymphocyte depletion but does not account for accelerated SIV pathogenesis
por: Okoye, Afam, et al.
Publicado: (2009)

Profound early control of highly pathogenic SIV by an effector-memory T cell vaccine
por: Hansen, Scott G., et al.
Publicado: (2011)

Effector-memory T cell responses are associated with protection of rhesus monkeys from mucosal SIV challenge
por: Hansen, Scott G., et al.
Publicado: (2009)

Immune clearance of highly pathogenic SIV infection
por: Hansen, Scott G., et al.
Publicado: (2013)

Progressive CD4(+) central–memory T cell decline results in CD4(+) effector–memory insufficiency and overt disease in chronic SIV infection
por: Okoye, Afam, et al.
Publicado: (2007)

Progressive CD4(+) central–memory T cell decline results in CD4(+) effector–memory insufficiency and overt disease in chronic SIV infection
por: Okoye, Afam, et al.
Publicado: (2007)

Naive T cells are dispensable for memory CD4(+) T cell homeostasis in progressive simian immunodeficiency virus infection
por: Okoye, Afam A., et al.
Publicado: (2012)

Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy
por: Barrenäs, Fredrik, et al.
Publicado: (2021)

The ingenol-based protein kinase C agonist GSK445A is a potent inducer of HIV and SIV RNA transcription
por: Okoye, Afam A., et al.
Publicado: (2022)

Insufficient Production and Tissue Delivery of CD4(+)Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection
por: Picker, Louis J., et al.
Publicado: (2004)

Immunization with Single-Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIV(mac)239
por: Jia, Bin, et al.
Publicado: (2009)

SIV Vpx Is Essential for Macrophage Infection but Not for Development of AIDS
por: Westmoreland, Susan V., et al.
Publicado: (2014)

Induction of a virus-specific effector–memory CD4(+) T cell response by attenuated SIV infection
por: Gauduin, Marie-Claire, et al.
Publicado: (2006)

ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIV(mac)251 Challenge
por: Alpert, Michael D., et al.
Publicado: (2012)

Distinct Phenotype, Longitudinal Changes of Numbers and Cell-Associated Virus in Blood Dendritic Cells in SIV-Infected CD8-Lymphocyte Depleted Macaques
por: Soulas, Caroline, et al.
Publicado: (2015)

IFN-α blockade during ART-treated SIV infection lowers tissue vDNA, rescues immune function, and improves overall health
por: Swainson, Louise A., et al.
Publicado: (2022)

Defining HIV and SIV Reservoirs in Lymphoid Tissues
por: Deleage, Claire, et al.
Publicado: (2016)

A Tonsillar PolyICLC/AT-2 SIV Therapeutic Vaccine Maintains Low Viremia Following Antiretroviral Therapy Cessation
por: Vagenas, Panagiotis, et al.
Publicado: (2010)

Effects of Treatment with Suppressive Combination Antiretroviral Drug Therapy and the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid; (SAHA) on SIV-Infected Chinese Rhesus Macaques
por: Ling, Binhua, et al.
Publicado: (2014)

Persistent Low-Level Replication of SIVΔnef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV Infection
por: Adnan, Sama, et al.
Publicado: (2016)

Gammaherpesvirus infection and malignant disease in rhesus macaques experimentally infected with SIV or SHIV
por: Marshall, Vickie A., et al.
Publicado: (2018)

CD8 T Cell Response Maturation Defined by Anentropic Specificity and Repertoire Depth Correlates with SIVΔnef-induced Protection
por: Adnan, Sama, et al.
Publicado: (2015)

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?
por: Sekaly, Rafick-Pierre
Publicado: (2008)

Engagement of monocytes, NK cells, and CD4(+) Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIV(mac251) vaginal acquisition
por: Gorini, Giacomo, et al.
Publicado: (2020)

Location and Dynamics of the Immunodominant CD8 T Cell Response to SIVΔnef Immunization and SIVmac251 Vaginal Challenge
por: Sasikala-Appukuttan, Arun K., et al.
Publicado: (2013)

Predictors of SIV recrudescence following antiretroviral treatment interruption
por: Pinkevych, Mykola, et al.
Publicado: (2019)

Antimicrobial prophylaxis does not improve post-surgical outcomes in SIV/SHIV-uninfected or SIV/SHIV-infected macaques (Macaca mulatta and Macaca fascicularis) based on a retrospective analysis
por: Moats, Cassandra, et al.
Publicado: (2022)

Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV
por: Martinez-Navio, José M., et al.
Publicado: (2020)

Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infection
por: Hao, Xing Pei, et al.
Publicado: (2015)

Rapamycin limits CD4(+) T cell proliferation in simian immunodeficiency virus–infected rhesus macaques on antiretroviral therapy
por: Varco-Merth, Benjamin D., et al.
Publicado: (2022)

Glycerol monolaurate prevents mucosal SIV transmission
por: Li, Qingsheng, et al.
Publicado: (2009)

Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy
por: Fennessey, Christine M., et al.
Publicado: (2017)

A cellular trafficking signal in the SIV envelope protein cytoplasmic domain is strongly selected for in pathogenic infection
por: Lawrence, Scott P., et al.
Publicado: (2022)

CD4 T cell Responses in the CNS during SIV infection
por: Elizaldi, Sonny R, et al.
Publicado: (2023)

Electron Tomography of the Contact between T Cells and SIV/HIV-1: Implications for Viral Entry
por: Sougrat, Rachid, et al.
Publicado: (2007)

Cytotoxic Capacity of SIV-Specific CD8(+) T Cells against Primary Autologous Targets Correlates with Immune Control in SIV-Infected Rhesus Macaques
por: Mendoza, Daniel, et al.
Publicado: (2013)

Low-level alternative tRNA priming of reverse transcription of HIV-1 and SIV in vivo
por: Fennessey, Christine M., et al.
Publicado: (2019)

Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy
por: Harper, Justin, et al.
Publicado: (2022)

Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challenge
por: Hansen, Scott G., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t4gcttbtcoc9aoo9m8878gl0t4